Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AECP
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
AECP, an aqueous extract derived from the fruit of *Crataegus pinnatifida Bge. var. major N.E.Br.* (a type of hawthorn), is a natural product investigated for its potential in treating cardiovascular diseases such as atherosclerosis. It is believed to exert its therapeutic effects through multiple mechanisms, including lipid-lowering, anti-inflammatory, and endothelial-protective activities, similar to some actions of statins. This extract is a traditional Chinese medicine ingredient and is being studied as an alternative or complementary therapy for conditions like hyperlipidemia and atherosclerosis.
- Other names
- aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit
Beyond the preview
Go deeper on AECP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AECP.